Published in Medical Patent Week, May 13th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Antares Pharma, Inc.
Report 1: Antares Pharma, Inc. (Amex:AIS) announced receipt of Notice of Allowance from the United States Patent & Trademark Office (USPTO) covering semi-solid pharmaceutical compositions used in its Advanced Transdermal Delivery (ATD(TM)) technology. The USPTO has stated that it intends to grant patent protection which covers hormonal and non-hormonal formulations developed by Antares Pharma. The patent is expected to issue mid-year and will remain in force until...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.